 STANS, SWITZERLAND ACCESSWIRE August 5, 2021 NLS Pharmaceutics Ltd. NASDAQ:NLSP, NLSPW NLS or the Company, a Swiss clinical-stage pharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announces that Alex Zwyer, Chief Executive Officer and Co-Founder, is scheduled to present at the Canaccord Genuity 41st Annual Growth Conference being held virtually August 10-12, 2021. 